BioSpace News Archive

The Medicrea® Group (Euronext Growth Paris: FR0004178572 - ALMED), pioneering the convergence of healthcare IT and next-generation, outcome-centered spinal device design and manufacturing with UNiD ASI™ (Adaptive Spine Intelligence) technology, announced today that the Company has signed a joint-venture agreement with Motion Medical

BioConsortia, Inc., innovator of microbial solutions for natural plant trait enhancement and yield improvement, has closed a further round of equity financing to support its continued growth, research achievements and development of superior products.

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of Eversense®, a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced a favorable outcome of the U.S. Food and Drug Administration (FDA) Clinical Chemistry and Clinical Toxicology Devices meeting on the Eversense system.

DotLab announced the results from a new study showing that its endometriosis test, which aids in diagnosing the disease, has the potential to also be used to monitor disease progression and response to therapy.

A proposed $54 million settlement has been reached in a class action lawsuit regarding the prescription drug Aggrenox® (aspirin/extended-release dipyridamole).